Abstract
Despite increased awareness, prevention campaigns, and tighter laws and regulations, alcohol consumption caused an average of 88,000 deaths per year and a burden of $249 billion to the U.S economy in 2010. Only three FDA-approved drugs, disulfiram, naltrexone and acamprosate are available for the treatment of alcohol use disorder. These drugs are only effective modestly and patient compliance is a serious issue because of several adverse side effects, necessitating the developments of newer drugs. The current research drug development efforts remains in the identification new alcohol targets and elucidating the molecular mechanism of its action is needed for effective intervention. In addition, current treatment could be improved by testing the existing medications for comorbid conditions using the patient's genetic background information.
References
Nov 1, 1984·Pharmacology, Biochemistry, and Behavior·F BoismareJ Durlach
Sep 10, 2002·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Giovanni AddoloratoGiovanni Gasbarrini
Jun 21, 2005·CNS Drugs·Philippe De WitteGeorge Koob
Oct 11, 2007·JAMA : the Journal of the American Medical Association·Bankole A JohnsonUNKNOWN Topiramate for Alcoholism Study Group
Dec 11, 2007·Lancet·Giovanni AddoloratoGiovanni Gasbarrini
Mar 6, 2010·CNS & Neurological Disorders Drug Targets·Lara A RayKaren Miotto
Mar 6, 2010·CNS & Neurological Disorders Drug Targets·Barbara J Mason, Charles J Heyser
May 21, 2010·Current Pharmaceutical Design·Falk Kiefer, Karl Mann
Jan 6, 2012·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Yi ShenJing Liang
Jan 17, 2012·Addictive Behaviors·L LeggioG Addolorato
Mar 23, 2012·Nature·Aashish ManglikSébastien Granier
May 1, 2012·Pharmacological Reviews·Vindhya KoppakaVasilis Vasiliou
May 23, 2013·Journal of Neurochemistry·Joydip DasGregg W Roman
Jul 30, 2014·Acta Pharmacologica Sinica·Jing Liang, Richard W Olsen
Sep 5, 2014·Substance Abuse and Rehabilitation·François Paille, Hervé Martini
Sep 27, 2014·Expert Opinion on Drug Discovery·Peter R KufahlM Foster Olive
Aug 8, 2015·Nature·Weijiao HuangBrian K Kobilka
Oct 20, 2015·American Journal of Preventive Medicine·Jeffrey J SacksRobert D Brewer
Dec 24, 2015·PLoS Medicine·Clément PalpacuerFlorian Naudet
Feb 19, 2016·Scientific Reports·Teresa KasererDaniela Schuster